Hematology TimesNovel delivery system could treat MCLJanuary 6, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesMutations could be therapeutic target for FLJanuary 5, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesEZH2 inhibitor can produce durable responsesDecember 31, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesAntibody shows promise for treating CLLDecember 22, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesVenetoclax produces deep responses in ultra-high-risk CLLDecember 17, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesSurprising finding in upfront use of idelalisib monotherapyDecember 15, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesCombination offers ‘important new option’ for CLL, team saysDecember 13, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesFDA approves rapid-infusion bendamustineDecember 11, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesTriplet disappoints in follicular lymphoma trialDecember 11, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology Times2nd-gen BTK inhibitor may be safer, team saysDecember 10, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesFDA grants KTE-C19 breakthrough designationDecember 10, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesCAR exhibits activity in resistant B-cell malignanciesDecember 9, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin Lymphoma
Hematology TimesIbrutinib ‘treatment of choice’ in rel/ref MCLDecember 8, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesTrial of ofatumumab in FL stopped earlyNovember 25, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesESRD treatments linked to different cancersNovember 13, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
